Syngene International Limited is a leading contract research, development, and manufacturing organisation (CRDMO) offering integrated scientific services from early discovery to commercial supply.

Established in 1993, Syngene specialises in both small and large molecules, catering to a broad spectrum of sectors, including pharmaceuticals, biotechnology, nutrition, animal health, consumer goods, and specialty chemicals.

The company collaborates with a diverse clientele, ranging from global multinationals to small and medium-sized enterprises, non-profit institutions, academic entities, and government organisations.

Headquartered in Bangalore, India, Syngene operates multiple campuses across Bangalore, Hyderabad, and Mangalore, each dedicated to various facets of research, development, and manufacturing.

With a workforce exceeding 8,000 employees, including over 5,600 scientists, Syngene is committed to delivering innovative scientific solutions that enhance human and animal health.

Key Products and Services

Discovery Services: Comprehensive early-stage research services encompassing target identification, validation, and lead optimisation.

Development Services: Extensive pre-clinical to clinical trial support, including process development, formulation development, analytical R&D, and regulatory submissions.

Manufacturing Services: cGMP-compliant facilities offering clinical supplies, registration batches, and commercial manufacturing for both small and large molecules.

Dedicated R&D Centres: Customised research centres providing dedicated multi-disciplinary scientific teams to support client-specific projects.

SynVent: A proprietary integrated drug discovery and development platform facilitating efficient advancement of programmes through target validation, translational interrogation, therapeutic discovery, and pre-clinical development for small molecules and biologics.

Conclusion

Syngene International Limited stands as a trusted partner in the global life sciences industry, providing end-to-end solutions that accelerate the journey from discovery to commercialisation. Their unwavering commitment to scientific excellence, innovation, and client satisfaction continues to drive advancements in human and animal health worldwide.